This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Array Biopharma(ARRY - Get Report) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. This stock is trading up 9.5% to $4.00 in recent trading.
Today's Range: $3.66-$4.10
52-Week Range: $1.58-$3.80
Volume: 1.9 million
Three-Month Average Volume: 864,369
Shares of ARRY are spiking higher after the company released positive data on its lung cancer drug, selumetinib, as well as its new melanoma treatment.
>>5 Under-$10 Stocks Poised for Breakouts
From a technical perspective, ARRY has started to flirt with a major breakout trade here since the stock is trending above some near-term overhead resistance at $3.73 to $3.80 with monster volume.
Traders should continue to look for long-biased trades in ARRY as long as it continues to trend above those overhead resistance levels with strong upside volume. I would consider upside volume that's near or above 864,369 shares as bullish. The next potential target for ARRY is its 2010 high of $4.25.